We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current APLI market cap is 4.24M. The company's latest EPS is CAD -0.0762 and P/E is -0.39.
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 2.17M | 886k | 1.29M | 2.45M | 472k |
| Operating Income | -4.37M | -5.4M | -14.37M | -23.56M | -7.78M |
| Net Income | -4.33M | -5.42M | -14.33M | -25.12M | -9.24M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 6.84M | 11.17M | 18.32M | 8.28M | 3.13M |
| Total Liabilities | 2.42M | 2.33M | 5.56M | 11.55M | 10.53M |
| Total Equity | 4.42M | 8.85M | 12.75M | -3.27M | -7.4M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -3.46M | -4.26M | -11.45M | -19.08M | -10.1M |
| Investing | -13k | -1,000 | -4.99M | 5.06M | -3k |
| Financing | 3.06M | 9.36M | 17.02M | 9.56M | 5.91M |
| Market Cap | 4.24M |
| Price to Earnings Ratio | -0.39 |
| Price to Sales Ratio | 7.69 |
| Price to Cash Ratio | 1.48 |
| Price to Book Ratio | -0.49 |
| Dividend Yield | - |
| Shares Outstanding | 121.27M |
| Average Volume (1 week) | 35.38k |
| Average Volume (1 Month) | 106.03k |
| 52 Week Change | -12.50% |
| 52 Week High | 0.08 |
| 52 Week Low | 0.025 |
| Spread (Intraday) | 0.01 (12.5%) |
| Company Name | Appili Therapeutics Inc |
| Address |
21-1344 summer street halifax, nova scotia B3H 0A8 |
| Website | https://www.appilitherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
